Theodore H. Schwartz

Professor

Icahn School of Medicine at Mount Sinai
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (24)

Year:

2026

Year:

2026

The endoscopic lateral transorbital approach (eLTOA) has emerged as a minimal access technique for accessing the middle fossa and periorbital region. This study explores the applicability of eLTOA in the management of recurrent and newly diagnosed medial temporal lobe gliomas. Forty patients at our institution underwent eLTOA between 2016 and 2024. There were five surgeries for glioma. Patients were assessed for demographic and clinical data, radiographic characteristics, and histopathological and molecular findings. Four recurrent gliomas required biopsy for diagnosis and molecular genotyping, and one newly diagnosed tumor aimed for gross total resection (GTR). Histologic diagnoses remained unchanged in three recurrent cases (two glioblastoma multiforme and one xanthoastrocytoma). One case was upgraded from oligoastrocytoma Grade II to glioblastoma Grade IV. GTR was achieved in the newly diagnosed tumor, with histology confirming dysembryoplastic neuroepithelial tumor. Average length of stay was 3 days. There was one case of transient diplopia. eLTOA offers a minimally invasive, direct approach to medial temporal lobe gliomas that minimizes the risks of infection and temporalis muscle atrophy associated with reoperation through a previously irradiated incision. It is most useful for restaging recurrent tumors, although GTR can be obtained in well-selected newly diagnosed tumors.

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Purpose: Transorbital endoscopic approaches to the skull base provide minimally invasive access with decreased surgical morbidity in appropriately selected cases. This study expands on the current understanding of transorbital neurological surgery by expanding the cohort, duration of follow-up, detailed ophthalmologic outcomes, and analysis. Methods: A retrospective consecutive case review was performed. Included subjects underwent lateral transorbital endoscope–assisted surgical approaches at a single center between 2016 and 2024. Subjects were stratified into 4 groups based on pathology (and/or) location: intradural, extradural, cavernous sinus and Meckel cave, and sphenoid wing meningiomas ± hyperostosis. Demographic information and ophthalmologic data were collected. Results: Thirty-five subjects were included: intracranial intradural (n = 8), intracranial extradural (n = 8), cavernous sinus and Meckel cave (n = 11), and sphenoid wing meningioma (n = 8). On average, visual acuity (VA) trended toward improvement in all groups except sphenoid wing meningioma; however, this trend did not reach statistical significance ( p = 0.39). Fifteen patients completed preoperative and postoperative Humphrey visual field testing. Overall, mean deviation scores trended toward improvement from –3.59 ± 4.28 to –1.82 ± 2.82 dB; however, this trend did not reach statistical significance ( p = 0.35). A similar trend was seen in all groups except the extradural group. There were statistically significant improvements in diplopia ( p = 0.01), extraocular motility ( p = 0.04), and exophthalmos ( p = 0.04) in all groups. Dyschromatopsia trended toward a decrease from 23% to 10% and, however, did not reach statistical significance ( p = 0.06). Transient diplopia, ptosis, and extraocular motility deficits were common but generally resolved; however, 66% of subjects had persistent postoperative V1 or V2 hypoesthesia. Conclusions: Visual outcomes were stable or improved in almost all patients. However, patients should be alerted to the possibility of persistent facial hypoesthesia. These results provide evidence that lateral transorbital endoscope–assisted approaches may have favorable ophthalmological morbidity profiles when performed by expert, multidisciplinary teams in carefully selected cases.

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Collaborators (10)

David Pisapia

Assistant Professor

Weill Cornell Medicine

UNITED STATES
View details

Ernest Bobeff

Assistant Professor

Medical University of Lodz

POLAND
View details

Nicolas Karakatsanis

Associate Professor of Biomedical Engineering

Weill Cornell Medical College

UNITED STATES
View details

Shirley Y. Su

-

UNITED STATES
View details

Wojciech Mlynarski

Head/Professor

Medical University of Lodz

POLAND
View details

Thomas Santarius

University of Cambridge

UNITED KINGDOM
View details

Bartosz Szmyd

Medical University of Lodz

POLAND
View details

Maria Fleseriu

Oregon Health & Science University

UNITED STATES
View details

Hugo Layard Horsfall

Imperial College London

UNITED KINGDOM
View details

Benjamin Liechty

Assistant Professor of Pathology and Laboratory Medicine

Weill Cornell Medicine

UNITED STATES
View details